reviewTop 10% cited
Use of the elevated plus maze in the search for novel anxiolytic agents
Trends in Pharmacological Sciences · 1995 · Vol. 16(2) · pp. 33–36
Gerard R. Dawson✉(MSD (UK) Limited (United Kingdom))Mark D. Tricklebank(MSD (UK) Limited (United Kingdom))
Neurotransmitter Receptor Influence on BehaviorNeuroscience and Neuropharmacology ResearchMemory and Neural MechanismsMicrogliaNeuroinflammationNeurodegenerationProgenitor cellTransplantationHippocampusMedicineNeuroscienceImmunologyBiology
MeSH terms
AnimalsDrug Evaluation, PreclinicalExploratory BehaviorMotor ActivityAnti-Anxiety AgentsMice
Citations
561
FWCI
6.01
field-weighted impact
References
15
Percentile
98%
vs. same field & year
Citations per year
Cited by
Ethological and temporal analyses of anxiety-like behavior: The elevated plus-maze model 20 years on
Neuroscience & Biobehavioral Reviews · 2005 · 984 citations
The use of the elevated plus maze as an assay of anxiety-related behavior in rodents
Nature Protocols · 2007 · 2,940 citations
Anxiety, defence and the elevated plus-maze
Neuroscience & Biobehavioral Reviews · 1997 · 984 citations
A multiple-test study of anxiety-related behaviours in six inbred rat strains
Behavioural Brain Research · 1997 · 501 citations
References
Behavioural and pharmacological characterisation of the elevated “zero-maze” as an animal model of anxiety
Psychopharmacology · 1994 · 739 citations
Anxiogenic stimuli in the elevated plus-maze
Pharmacology Biochemistry and Behavior · 1993 · 619 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.